Clicky

Suzuken CO Ltd(SZUKF)

Description: Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.


Keywords: Life Sciences Pharmacy Diabetes Diagnostic Products Pharmacy In China Pharmaceutical Industry In India Specialty Drugs In The United States Pharmaceutical Industry In Bangladesh Ethical Pharmaceuticals

Home Page: www.suzuken.co.jp

8 Higashi Kataha-machi
Nagoya, 461-8701
Japan
Phone: 81 52 961 2331


Officers

Name Title
Mr. Shigeru Asano Pres, CEO & Director
Mr. Yoshiki Bessho Supreme Advisor & Director
Mr. Hisashi Tamura Sr. Exec. Officer, Sr. GM of Corp. Management Headquarters & Director
Ms. Chie Takahashi GM of Pharmaceutical Affairs Supervisory Office, Exec. Officer & Director

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 17.9552
Price-to-Book MRQ: 0.6732
Price-to-Sales TTM: 0.001
IPO Date:
Fiscal Year End: March
Full Time Employees: 14032
Back to stocks